Risk of Heart-Related Death From Gout Medication

Preliminary results from a clinical safety trial of the gout medication febuxostat (Uloric) indicate that, when compared with allopurinol, the standard gout treatment, febuxostat increases the risk of heart-related deaths.The Food and Drug Administration will provide additional information after the final trial results are submitted and analyzed.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research